Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.2 USD | -0.75% | -12.95% | -40.19% |
Jun. 03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.19% | 3.68B | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.00% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Immunovant Insider Sold Shares Worth $490,697, According to a Recent SEC Filing